Back
NVIDIA Corp. Vs. Corbus Pharmaceuticals Holdings, Inc. Sector Stock Comparison
Sell
46
NVDA
NVIDIA Corp.
Last Price:
$171.12
Seasonality Move:
16.78%
Sell
23
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Last Price:
$8.14
Seasonality Move:
47.36%
Sell
46
NVIDIA Corp. (NVDA)
is a Sell
Is NVIDIA Corp. a Buy, Sell or Hold?
-
The current NVIDIA Corp. [NVDA] share price is $170.94. The Score for NVDA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NVDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings, Inc. a Buy, Sell or Hold?
-
The current Corbus Pharmaceuticals Holdings, Inc. [CRBP] share price is $8.15. The Score for CRBP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
CRBP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVDA Stock Price Chart
What is NVIDIA Corp.'s stock price today?
-
The NVIDIA Corp. share price today is $170.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVDA is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings, Inc.'s stock price today?
-
The Corbus Pharmaceuticals Holdings, Inc. share price today is $8.15Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
NVDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.89 | Sell |
| Relative Strength Index (14 RSI): | 37.15 | Sell |
| Chaikin Money Flow: | -174545724 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (176.93 - 186.63) | Sell |
| Bollinger Bands (100): | (174.5 - 190.18) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 25.22 | Sell |
| Chaikin Money Flow: | -231547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.69 - 11.69) | Sell |
| Bollinger Bands (100): | (8.84 - 14.48) | Sell |
NVDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 179.4 | Sell |
| 20-day SMA: | 180.28 | Sell |
| 50-day SMA: | 186.18 | Sell |
| 200-day SMA: | 156.92 | Buy |
| 8-day EMA: | 177.55 | Sell |
| 20-day EMA: | 180.79 | Sell |
| 50-day EMA: | 182.79 | Sell |
| 200-day EMA: | 164.14 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.55 | Sell |
| 20-day SMA: | 10.54 | Sell |
| 50-day SMA: | 12.92 | Sell |
| 200-day SMA: | 9.48 | Sell |
| 8-day EMA: | 9.37 | Sell |
| 20-day EMA: | 10.33 | Sell |
| 50-day EMA: | 11.28 | Sell |
| 200-day EMA: | 7.47 | Buy |
NVIDIA Corp. Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.19 per share, an increase this year of $1.72 per share, and an increase next year of $1.73 per share.
Corbus Pharmaceuticals Holdings, Inc. Earnings Growth & CRBP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.34 per share, and an increase next year of $1.49 per share.
NVIDIA Corp. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||